Clinical Trials Logo

Filter by:
NCT ID: NCT03637621 Active, not recruiting - Clinical trials for Distal Humerus Fracture

Retrospective Analysis on Distal Humerus Fractures

(DHFx)
Start date: January 7, 2018
Phase:
Study type: Observational

The purpose of this study is to evaluate preoperative objective measurements for distal humerus ORIF patients and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.

NCT ID: NCT03637608 Active, not recruiting - Clinical trials for Proximal Humeral Fracture

Proximal Humerus Fractures: A Retrospective Analysis

PHFx
Start date: December 7, 2017
Phase:
Study type: Observational

The purpose of this study is to evaluate preoperative objective measurements of patients with a proximal humerus fracture and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of open reduction, internal fixation surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.

NCT ID: NCT03637543 Active, not recruiting - Prostate Cancer Clinical Trials

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Start date: October 18, 2018
Phase: Phase 2
Study type: Interventional

This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer. The drug involved in this study is: -Nivolumab

NCT ID: NCT03636568 Active, not recruiting - Surgery Clinical Trials

Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)

DHAPS
Start date: June 2, 2016
Phase: N/A
Study type: Interventional

Hyponatremia is defined as sodium below the normal range of 135-145. Symptomatically, it can cause patients to experience a wide range of symptoms including lethargy, headache, nausea, vomiting and in severe cases coma and even death. The goal of this study is to prospectively compare two approaches to the postoperative fluid management of patients undergoing transsphenoidal resection of a pituitary tumor or cyst to decrease the occurrence of postoperative delayed hyponatremia. One group will be placed on moderate fluid restriction and the other group will be placed on ad lib fluid intake.

NCT ID: NCT03636503 Active, not recruiting - Follicular Lymphoma Clinical Trials

RITUXIMAB + IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA

Start date: October 30, 2018
Phase: Phase 1
Study type: Interventional

This research study is studying several new investigational drug combinations as a possible treatment for follicular lymphoma. The drugs involved are: - Rituximab - Utomilumab - Avelumab

NCT ID: NCT03636490 Active, not recruiting - Blood Pressure Clinical Trials

Stress, Salt Excretion, and Nighttime Blood Pressure

SABRE
Start date: November 16, 2018
Phase: N/A
Study type: Interventional

The study will examine urinary sodium excretion induced by psychological stress and its diurnal pattern as a novel biological mechanism that may underlie an abnormal diurnal pattern of blood pressure. The study will test the hypotheses that lower stress-induced sodium excretion is associated with an abnormal diurnal pattern of sodium excretion, and that an abnormal diurnal pattern of sodium excretion is associated with an abnormal diurnal pattern of blood pressure. Primary Aim 1: To examine the association between urinary sodium excretion after provoked psychological stress and the diurnal pattern of sodium excretion. Primary Aim 2: To examine the association between the diurnal pattern of sodium excretion and the diurnal pattern of BP. Secondary Aim: To examine whether the association between urinary sodium excretion after provoked stress and the diurnal pattern of sodium excretion is modified by ecological momentary levels of perceived stress, experienced during the daytime period. Exploratory Aim: To determine the socio-demographic, behavioral, and psychological traits, chronic stress, and biological stress-related factors that are associated with lower stress-induced sodium excretion. Identification of these factors will help determine who is at risk for having a differential sodium excretion response to psychological stress.

NCT ID: NCT03636438 Active, not recruiting - Clinical trials for Ornithine Transcarbamylase (OTC) Deficiency

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

CAPtivate
Start date: August 30, 2018
Phase:
Study type: Observational

Determine the long-term safety of DTX301 following a single intravenous (IV) dose in adults with late-onset ornithine transcarbamylase (OTC) deficiency.

NCT ID: NCT03636412 Active, not recruiting - Sarcopenia Clinical Trials

Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients

iFRAIL
Start date: August 15, 2018
Phase: N/A
Study type: Interventional

The objective of this study is to assess the feasibility and effectiveness of dedicated ambulator-assisted physical activity in lung transplant inpatients. The primary hypothesis is that an ambulator-assisted intervention for lung transplant patients will prove feasible and may result in improved frailty, hospital outcomes, including less need for inpatient rehabilitation and shorter length of stay in the hospital.

NCT ID: NCT03635892 Active, not recruiting - Clinical trials for Papillary Renal Cell Carcinoma

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Start date: August 13, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare any good and bad effects of using a combination of nivolumab (Opdivo®) and cabozantinib (Cabometyx®) in people with metastatic kidney cancer.

NCT ID: NCT03635814 Active, not recruiting - Clinical trials for Diabetic Macular Edema(DME)

The Study to YD312 Tablet in Patients With Diabetic Macular Edema

Start date: October 19, 2017
Phase: Phase 2
Study type: Interventional

This study objectives is to evaluate the efficacy of YD312 to improve visual acuity in patients with diabetic macular edema (DME) compared to placebo and determine optimal dose of phase 2b study.